Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Beam Technology Enables Less Harmful, More Accurate, and Cost-Effective Radiotherapy

By MedImaging International staff writers
Posted on 21 Apr 2014
Newly developed technology will enable more effective, less harmful, and drastically less costly radiotherapy and radiosurgery treatment using low-energy X-ray tubes instead of high-energy sources typically used today.

Convergent R.N.R., Ltd. (CRnR; Tirat Carmel, Israel) has completed a very effective and promising proof-of-concept session of the Mercy Beam technology.

The Mercy Beam introduces an advanced lens that gathers most of the X-rays emanating divergently out of any traditional X-ray tube (currently used for X-ray imaging) and converges it towards the tumor site. The lens simultaneously removes low-energy photons that would be absorbed by the patient’s skin. The convergence increases the therapeutic dose delivered at the tumor target, while the organs in the vicinity of the tumor receive a very low dose or no dose at all. The converging technology enables the use of photon-energy X-rays 100 times lower than those used by current systems that are based on linear accelerators (LINACs). This technology, because of its low energy requirement, enables a small, light and inexpensive solution in which the cancer is treated accurately with a concentrated radiation at a fraction of the cost of all other methods.

“Today’s radiation treatment and surgery uses very high energy X-ray radiation that not only penetrates the body to reach the tumor, but also scatters towards the surrounding environment including healthy tissue, causing unwanted damage,” said Zeev Harel, CEO of CRnR. “To deal with such high energy X-rays, the protocol requires the machine installation inside a room of several feet of concrete walls, and heavy lead doors, which make those solutions even more expensive. Mercy Beam would revolutionize cancer treatment as we know it today, allowing many patients to receive a merciful, efficient and affordable treatment. The use of low energy X-rays will enable operating the system in standard X-ray rooms [no need for ‘special bunkers’] and in the future even in vans/lorries/trailers that may travel to remote areas. The technology is targeted for treating many types of cancerous tumors with an emphasis on treating of small children.”

Convergent R.N.R. (CRnR) is a medical start-up company developing a new X-ray focusing technology called MercyBeam to perform cancer radiotherapy and radiosurgery. CRnR developed and patented the said break-through technology utilizing a standard imaging X-ray source to form a converging beam into a volume of treatment instead of the conventional diverging or collimated technologies existing today.

Related Links:

Convergent R.N.R.
Mercy Beam



Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Mobile Digital C-arm X-Ray System
HHMC-200D
Ultrasound Software
UltraExtend NX
Ultrasound Needle Guide
Ultra-Pro II
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to MedImaging.net and get complete access to news and events that shape the world of Radiology.
  • Free digital version edition of Medical Imaging International sent by email on regular basis
  • Free print version of Medical Imaging International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of Medical Imaging International in digital format
  • Free Medical Imaging International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Ultrasound

view channel
Image: CAM figures of testing images (Photo courtesy of SPJ; DOI:10.34133/research.0319)

Diagnostic System Automatically Analyzes TTE Images to Identify Congenital Heart Disease

Congenital heart disease (CHD) is one of the most prevalent congenital anomalies worldwide, presenting substantial health and financial challenges for affected patients. Early detection and treatment of... Read more

Nuclear Medicine

view channel
Image: Researchers have identified a new imaging biomarker for tumor responses to ICB therapy (Photo courtesy of 123RF)

New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy

Immunotherapies, such as immune checkpoint blockade (ICB), have shown promising clinical results in treating melanoma, non-small cell lung cancer, and other tumor types. However, the effectiveness of these... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.